Eli Lilly has signed a heavily…
Eli Lilly has signed a heavily backloaded agreement to license [...]
Eli Lilly has signed a heavily backloaded agreement to license [...]
With a pair of phase 2 readouts, AstraZeneca is positioning [...]
A conversation with Gina Kolata, who covers breakthroughs in medical [...]
Looking to spark an antibody-like revolution for RNA interference medicines, [...]
With an obesity green light already in hand, Eli Lilly [...]
Eli Lilly emerged as the “clear winner from ADA,” according [...]
Actress Mariska Hargitay looks back on her late father’s multiple [...]
For Novo Nordisk, the launch of the company’s highly anticipated [...]
Treeline Biosciences, an under-the-radar cancer company that has raised more [...]
The FDA has expanded the label for Pfizer’s Hympavzi, now [...]